Skip to main content

Soltis Investment Advisors LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1802530 ST. GEORGE, UT

Position in REGN

as of Mar 31, 2026 · filed Apr 27, 2026
Position Value
$769,549
+$104,198 QoQ
Shares Held
996
+15.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 84% Shared 0% None 16%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Soltis Investment Advisors LLC holds $1,414,684 across 4 Biotechnology names. REGN ranks #1 (54.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
This page
996 $769,549

All Filings in REGN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $769,549 996
2025-12-31 $665,351 862
2025-09-30 $348,045 619
2025-06-30 $334,950 638
2025-03-31 $416,054 656
2024-12-31 $482,247 677
2024-09-30 $747,431 711
2024-06-30 $717,853 683
2024-03-31 $648,718 674
2023-12-31 $599,872 683
2023-09-30 $596,646 725
2023-06-30 $527,408 734
2023-03-31 $609,679 742
2022-12-31 $501,435 695
2022-09-30 $485,653 705
2022-06-30 $379,505 642
2022-03-31 $440,703 631
2021-12-31 $370,070 586
2021-09-30 $355,845 588
2021-06-30 $326,187 584
2021-03-31 $262,592 555
2020-12-31 $262,811 544
2020-09-30 $297,243 531
2020-06-30 $311,825 500
2020-03-31 $244,145 500